Roche has joined Big Pharma peers…
Roche has joined Big Pharma peers in the emerging degrader-antibody [...]
With a solid year of double-digit…
With a solid year of double-digit revenue growth in the [...]
Johnson & Johnson’s…
Johnson & Johnson’s immunology drug Tremfya is looking to challenge [...]
Jeito Capital has hailed the $1.2…
Jeito Capital has hailed the $1.2 billion it has secured [...]
After entering 2026 hungry for…
After entering 2026 hungry for deals, Gilead Sciences has wasted [...]
Following a research collaboration…
Following a research collaboration established in 2021, Astellas Pharma has [...]
Three years after its…
Three years after its OrbiMed-backed series A in 2023, Sidewinder [...]
The plummeting demand for…
The plummeting demand for Merck’s HPV vaccine Gardasil in China [...]
Halozyme is putting a recent…
Halozyme is putting a recent drug-delivery acquisition to work thanks [...]
The FDA is seeking new powers to…
The FDA is seeking new powers to hold companies accountable [...]